[New antihypertensive agents].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007741:Labetalol / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004232:Diuretics; D000804:Angiotensin II; D008914:Minoxidil; D007741:Labetalol; D011224:Prazosin
Neue Antihypertonika.